These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 19152200)

  • 1. The impact of cigarette smoking on stimulant addiction.
    Weinberger AH; Sofuoglu M
    Am J Drug Alcohol Abuse; 2009; 35(1):12-7. PubMed ID: 19152200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals.
    Winhusen T; Stitzer M; Woody G; Brigham G; Kropp F; Ghitza U; Lindblad R; Adinoff B; Green C; Sharma G; Somoza E
    Contemp Clin Trials; 2012 Jan; 33(1):197-205. PubMed ID: 22005174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.
    Wilens TE; Adamson J; Monuteaux MC; Faraone SV; Schillinger M; Westerberg D; Biederman J
    Arch Pediatr Adolesc Med; 2008 Oct; 162(10):916-21. PubMed ID: 18838643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine and cognitive efficiency in alcoholics and illicit stimulant abusers: implications of smoking cessation for substance users in treatment.
    Ceballos NA; Tivis R; Lawton-Craddock A; Nixond SJ
    Subst Use Misuse; 2006; 41(3):265-81. PubMed ID: 16467005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic functioning in stimulant addiction: implications for medications development.
    Sofuoglu M; Mooney M
    CNS Drugs; 2009 Nov; 23(11):939-52. PubMed ID: 19845415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk and protective factors for methamphetamine use and nonmedical use of prescription stimulants among young adults aged 18 to 25.
    Herman-Stahl MA; Krebs CP; Kroutil LA; Heller DC
    Addict Behav; 2007 May; 32(5):1003-15. PubMed ID: 16920275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large Cigars: Smoking Topography and Toxicant Exposure.
    Rosenberry ZR; Pickworth WB; Koszowski B
    Nicotine Tob Res; 2018 Jan; 20(2):183-191. PubMed ID: 27798089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disrupting nicotine reinforcement: from cigarette to brain.
    Rose JE
    Ann N Y Acad Sci; 2008 Oct; 1141():233-56. PubMed ID: 18991961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and chemical effects of cigarette additives.
    Rabinoff M; Caskey N; Rissling A; Park C
    Am J Public Health; 2007 Nov; 97(11):1981-91. PubMed ID: 17666709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of E-cigarettes on Smoking and Related Outcomes in Veteran Smokers With Psychiatric Comorbidity.
    Valentine GW; Hefner K; Jatlow PI; Rosenheck RA; Gueorguieva R; Sofuoglu M
    J Dual Diagn; 2018; 14(1):2-13. PubMed ID: 29083287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine-containing versus de-nicotinized cigarettes: effects on craving and withdrawal.
    Gross J; Lee J; Stitzer ML
    Pharmacol Biochem Behav; 1997; 57(1-2):159-65. PubMed ID: 9164567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Role for Sigma Receptors in Stimulant Self-Administration and Addiction.
    Katz JL; Hiranita T; Hong WC; Job MO; McCurdy CR
    Handb Exp Pharmacol; 2017; 244():177-218. PubMed ID: 28110353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing the addictiveness of cigarettes. Council on Scientific Affairs, American Medical Association.
    Henningfield JE; Benowitz NL; Slade J; Houston TP; Davis RM; Deitchman SD
    Tob Control; 1998; 7(3):281-93. PubMed ID: 9825424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulant Use Disorders.
    Park TM; Haning WF
    Child Adolesc Psychiatr Clin N Am; 2016 Jul; 25(3):461-71. PubMed ID: 27338967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET studies of the influences of nicotine on neural systems in cigarette smokers.
    Rose JE; Behm FM; Westman EC; Mathew RJ; London ED; Hawk TC; Turkington TG; Coleman RE
    Am J Psychiatry; 2003 Feb; 160(2):323-33. PubMed ID: 12562580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in self-reported decision-making styles in stimulant-dependent and opiate-dependent individuals.
    Gorodetzky H; Sahakian BJ; Robbins TW; Ersche KD
    Psychiatry Res; 2011 Apr; 186(2-3):437-40. PubMed ID: 20797802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulant Use in Pregnancy: An Under-recognized Epidemic Among Pregnant Women.
    Smid MC; Metz TD; Gordon AJ
    Clin Obstet Gynecol; 2019 Mar; 62(1):168-184. PubMed ID: 30601144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal tobacco smoking, nicotine replacement and neurobehavioural development.
    Pauly JR; Slotkin TA
    Acta Paediatr; 2008 Oct; 97(10):1331-7. PubMed ID: 18554275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive Deficits in Methamphetamine Users: How Strong is The Evidence?
    Proebstl L; Kamp F; Koller G; Soyka M
    Pharmacopsychiatry; 2018 Nov; 51(6):243-250. PubMed ID: 29334687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The decline in lung cancer and the genetics of nicotine addiction.
    Morrison PJ
    Ulster Med J; 2007 May; 76(2):65. PubMed ID: 17476817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.